Skip to content

Clinical study of acupuncture in the treatment of depressive disorders in adolescents

Clinical study of acupuncture in the treatment of depression in adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000186
Enrollment
Unknown
Registered
2024-08-07
Start date
2024-08-15
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Sponsors

The Affiliated TCM Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1) 12 years<=Age<18 years; 2) Meet DSM-5 diagnostic criteria for "depressive disorders"; 3) Meet mild (8 = 17-item Hamilton Depression Rating Scale score <14) and moderate (14 = 17-item Hamilton Depression Rating Scale score <20); 4) No suicide risk, a "no" response on all items of the Suicide Severity Rating Scale (C-SSRS), and a score of <3 on item 3 (suicide) of the HAMD-17; 5) Have not been treated with antidepressants (escitalopram, mirtazapine, etc.) and physical therapy (acupuncture, transcranial magnetic stimulation, transcranial electrical stimulation, electroconvulsive therapy, etc.) within the previous 1 month; 6) The study subjects and their guardians refused to take the medication; 7) Reads and writes properly and is able to communicate properly; 8) The study subjects and their guardians volunteered to participate in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Currently or previously suffered from a diagnosis consistent with other mental disorders in the DSM-5, such as bipolar disorder, schizophrenia, post-traumatic stress disorder, and personality disorders; 2) Patients with severe or unstable cardiovascular, respiratory, hepatic, renal, hematologic, or other systemic diseases, as well as patients with acute illnesses, infectious diseases, or malignant tumors, who, in the opinion of the investigator, are not suitable for enrollment in this stud; 3) Presence of a history of psychoactive substance (e.g., alcohol, drugs, etc.) abuse or dependence.

Design outcomes

Primary

MeasureTime frame
Difference in Children's Depression Rating Scale - Revised (CDRS-R) scores;

Secondary

MeasureTime frame
PSQI scale score difference;Difference in Children's Depression Rating Scale - Revised (CDRS-R) scores;Clinical remission rate(HAMD-17 score <7 after 8 weeks of treatment);C-SSRS scale score difference;HAMD-17 clinical reduction rate( = pre-treatment HAMD-17 score - post-treatment HAMD-17 score)/Pre-treatment HAMD-17 score;HAMA-14 scale score difference;HAMD-17 scale score difference;

Countries

China

Contacts

Public ContactLin Yu

The Affiliated TCM Hospital of Guangzhou Medical University

yul@gzhmu.edu.cn+86 134 3020 0806

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026